Hemispherx BioPharma, Inc. (AMEX:HEB)
| CAPS Rating |
|
|---|---|
| Open | $0.34 |
| Previous Close | $0.34 |
| Daily Range | $0.33 - $0.37 |
| 52-Week Range | $0.17 - $0.57 |
| Market Cap | $50.13M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 737,775 |
| Average Daily Volume | 0 |
HEB
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
HEB Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
HEB News and Commentary
- Mediocre 4Q for H-P - Analyst Blog – NASDAQ
- One Small Cap for the Coming Rally – The Motley Fool
- Three Penny Stocks to Avoid (HEB) (CIT) (IRLD) – Blog at The Motley Fool
- Buy Before It's Too Late – The Motley Fool
- What are some pharmaceutical stocks that will be reviewed by the FDA soon? – Blog at The Motley Fool
- Correct me if I am wrong, but I think I have found a gem – Blog at The Motley Fool
- H1N1 R&D Biotechs, More Virulent Than The Flu Strain Itself? – Blog at The Motley Fool
- This Move Cost Index Funds Big Money – The Motley Fool
- 6 Stocks to Sell Before Everyone Else Does – The Motley Fool
- Where do the picks come from? – Blog at The Motley Fool
- 5 Stocks Bucking the Downtrend – The Motley Fool
- No More Biotech Shorts for JakilaTheHun (Damn You HEB!) – Blog at The Motley Fool
- Hemispherix Bio is a complete scam – Blog at The Motley Fool
- Hemispherx Biopharm (HEB) Explosive Rally Biotech PDUFA decision coming soon! – Blog at The Motley Fool
- 5 Deathbed Stocks? – The Motley Fool
- The CASE for Hemispherx Biopharma. DRUGS for the gambler! – Blog at The Motley Fool
- Hemispherx Biopharma, Inc. – Blog at The Motley Fool
- 7 Surprising 1-Star Stocks – The Motley Fool
RSS Headlines
Fool UK
